Table 1 Characteristics of the deceased or alive patients at 120 days
Risk factors | Total (n = 244) | Alive patients (n = 159) | Deceased patients (n = 85) | P |
|---|---|---|---|---|
Age (mean) | 73.02 ± 13.39 | 72.66 ± 14.63 | 73.69 ± 10.73 | 0.5 |
Sex male | 131 (53.7 %) | 87 (54.7 %) | 44 (51.8 %) | 0.6 |
Hypertension | 155 (63.5 %) | 98 (61.6 %) | 57 (67.1 %) | 0.4 |
Diabetes mellitus | 71 (29.1 %) | 48 (30.2 %) | 23 (27.1 %) | 0.6 |
Hypercholesterolemia | 37 (15.2 %) | 26 (16.3 %) | 11 (12.9 %) | 0.5 |
Hypertrygliceridemia | 16 (6.5 %) | 11 (6.9 %) | 5 (5.9 %) | 1.0 |
Current smoking | 20 (8.2 %) | 12 (7.5 %) | 8 (9.4 %) | 0.6 |
TIA history | 8 (3.3 %) | 5 (3.1 %) | 3 (3.5 %) | 1.0 |
Stroke recurrence | 44 (18.0 %) | 31 (19.5 %) | 13 (15.3 %) | 0.4 |
Ischemic heart disease | 69 (28.3 %) | 40 (25.1 %) | 29 (34.1 %) | 0.08 |
Atrial fibrillation | 10 (4.1 %) | 6 (3.8 %) | 4 (4.7 %) | 0.7 |
Carotid atherosclerosis | 27 (11.1 %) | 19 (12.0 %) | 8 (9.4 %) | 0.6 |
Ischemic stroke (qualifying event) | 210 (86.1 %) | 140 (88.1 %) | 70 (82.3 %) | 0.2 |
Non-lacunar stroke | 120 (49.2 %) | 73 (45.9 %) | 47 (52.3 %) | 0.04 |
NIHSS on admission (mean) | 8.78 ± 6.22 | 7.79 ± 5.92 | 10.14 ± 6.37 | 0.001 |
Hyperhomocysteimenia | 106 (43.4 %) | 65 (40.9 %) | 41 (48.2 %) | 0.2 |
PCR increase | 98 (40.2 %) | 51 (30.1 %) | 47 (55.3 %) | 0.001 |
Stroke Panel >4 | 161 (66.0 %) | 93 (58.5 %) | 68 (80.0 %) | 0.001 |